BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 29579032)

  • 1. Vertical Growth Phase as a Prognostic Factor for Sentinel Lymph Node Positivity in Thin Melanomas: A Systematic Review and Meta-Analysis.
    Appleton SE; Fadel Z; Williams JS; Bezuhly M
    Plast Reconstr Surg; 2018 Jun; 141(6):1529-1540. PubMed ID: 29579032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between tumor-infiltrating lymphocytes and sentinel lymph node positivity in thin melanoma.
    Santos FMD; Silva FCD; Pedron J; Furian RD; Fortes C; Bonamigo RR
    An Bras Dermatol; 2019; 94(1):47-51. PubMed ID: 30726463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of sentinel lymph node positivity in thin melanoma using the National Cancer Database.
    Conic RRZ; Ko J; Damiani G; Funchain P; Knackstedt T; Vij A; Vidimos A; Gastman BR
    J Am Acad Dermatol; 2019 Feb; 80(2):441-447. PubMed ID: 30240775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is it Necessary to Perform Sentinel Lymph Node Biopsy in Thin Melanoma? A Retrospective Single Center Analysis.
    Kocsis A; Karsko L; Kurgyis Z; Besenyi Z; Pavics L; Dosa-Racz E; Kis E; Baltas E; Ocsai H; Varga E; Bende B; Varga A; Mohos G; Korom I; Varga J; Kemeny L; Nemeth IB; Olah J
    Pathol Oncol Res; 2020 Jul; 26(3):1861-1868. PubMed ID: 31792874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel lymph node biopsy in patients with thin melanomas: Frequency and predictors of metastasis based on analysis of two large international cohorts.
    Isaksson K; Nielsen K; Mikiver R; Nieweg OE; Scolyer RA; Thompson JF; Ingvar C
    J Surg Oncol; 2018 Sep; 118(4):599-605. PubMed ID: 30196533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should Sentinel Lymph Node Biopsy Be Performed for All T1b Melanomas in the New 8
    Egger ME; Stevenson M; Bhutiani N; Jordan AC; Scoggins CR; Philips P; Martin RC; McMasters KM
    J Am Coll Surg; 2019 Apr; 228(4):466-472. PubMed ID: 30660817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transected thin melanoma: Implications for sentinel lymph node staging.
    Herbert G; Karakousis GC; Bartlett EK; Zaheer S; Graham D; Czerniecki BJ; Fraker DL; Ariyan C; Coit DG; Brady MS
    J Surg Oncol; 2018 Mar; 117(4):567-571. PubMed ID: 29194673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival analysis and sentinel lymph node status in thin cutaneous melanoma: A multicenter observational study.
    Tejera-Vaquerizo A; Ribero S; Puig S; Boada A; Paradela S; Moreno-Ramírez D; Cañueto J; de Unamuno B; Brinca A; Descalzo-Gallego MA; Osella-Abate S; Cassoni P; Carrera C; Vidal-Sicart S; Bennássar A; Rull R; Alos L; Requena C; Bolumar I; Traves V; Pla Á; Fernández-Orland A; Jaka A; Fernández-Figueres MT; Hilari JM; Giménez-Xavier P; Vieira R; Botella-Estrada R; Román-Curto C; Ferrándiz L; Iglesias-Pena N; Ferrándiz C; Malvehy J; Quaglino P; Nagore E;
    Cancer Med; 2019 Aug; 8(9):4235-4244. PubMed ID: 31215168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sentinel lymph node biopsy for melanoma: experience with 234 consecutive procedures.
    Wagner JD; Corbett L; Park HM; Davidson D; Coleman JJ; Havlik RJ; Hayes JT
    Plast Reconstr Surg; 2000 May; 105(6):1956-66. PubMed ID: 10839392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma.
    Han D; Zager JS; Shyr Y; Chen H; Berry LD; Iyengar S; Djulbegovic M; Weber JL; Marzban SS; Sondak VK; Messina JL; Vetto JT; White RL; Pockaj B; Mozzillo N; Charney KJ; Avisar E; Krouse R; Kashani-Sabet M; Leong SP
    J Clin Oncol; 2013 Dec; 31(35):4387-93. PubMed ID: 24190111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
    Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
    Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of Sentinel Lymph Node Metastasis in Patients with Thin Melanoma: An International Multi-institutional Collaboration.
    Walker RJB; Look Hong NJ; Moncrieff M; van Akkooi ACJ; Jost E; Nessim C; van Houdt WJ; Stahlie EHA; Seo C; Quan ML; McKinnon JG; Wright FC; Mavros MN
    Ann Surg Oncol; 2022 Oct; 29(11):7010-7017. PubMed ID: 35676603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Mitotic Rate Predicts Sentinel Lymph Node Involvement in Thin Melanomas.
    Skochdopole AJ; Kutlu OC; Engelhardt KE; Lancaster WP; Abbott AM; Camp ER
    J Surg Res; 2020 Dec; 256():198-205. PubMed ID: 32711176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
    Nahabedian MY; Tufaro AP; Manson PN
    Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas.
    Wat H; Senthilselvan A; Salopek TG
    J Am Acad Dermatol; 2016 Jan; 74(1):94-101. PubMed ID: 26542815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitotic rate as a predictive factor for positive sentinel lymph nodes in pT1 and pT2 melanomas.
    Fidanzi C; Bevilacqua M; D'Erme AM; Morganti R; Viacava P; Manzo Margiotta F; Romanelli M; Dini V; Janowska A; Bagnoni G
    J Plast Reconstr Aesthet Surg; 2023 Aug; 83():215-220. PubMed ID: 37279633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel node biopsy in thin and thick melanoma.
    Mozzillo N; Pennacchioli E; Gandini S; Caracò C; Crispo A; Botti G; Lastoria S; Barberis M; Verrecchia F; Testori A
    Ann Surg Oncol; 2013 Aug; 20(8):2780-6. PubMed ID: 23720068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of sentinel lymph node status of cutaneous melanoma in Serbian patients.
    Jokic S; Markovic I; Bukumiric Z; Jokic V; Rakovic M; Tripkovic J; Stojiljkovic D; Spurnic I; Jevric M; Matic M; Dobrosavljevic D
    J BUON; 2018; 23(2):468-474. PubMed ID: 29745094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Patient Age and Lymph Node Positivity in Thin Melanoma.
    Sinnamon AJ; Neuwirth MG; Yalamanchi P; Gimotty P; Elder DE; Xu X; Kelz RR; Roses RE; Chu EY; Ming ME; Fraker DL; Karakousis GC
    JAMA Dermatol; 2017 Sep; 153(9):866-873. PubMed ID: 28724122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.